Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "C"

10617 News Found

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
Digitisation | May 07, 2026

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion

Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows


CARE Hospitals performs rare organ-preserving pancreatic surgery
Hospitals | May 07, 2026

CARE Hospitals performs rare organ-preserving pancreatic surgery

Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


Free HLA typing for children with thalassaemia launched in India
Healthcare | May 07, 2026

Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia


China poised to launch world’s first CAR-T therapy for gastric cancer
Biopharma | May 07, 2026

China poised to launch world’s first CAR-T therapy for gastric cancer

As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies


Neurobion introduces nerve pain relief cream
Healthcare | May 07, 2026

Neurobion introduces nerve pain relief cream

The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil


GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD
Clinical Trials | May 07, 2026

GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD

This is an exciting and meaningful milestone for GRIN Therapeutics


Merck completes $5.8 billion acquisition of Terns Pharma
News | May 07, 2026

Merck completes $5.8 billion acquisition of Terns Pharma

At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia